Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In adipose models, reduced NNMT activity has been linked with smaller adipocyte size and diminished fat depots, suggesting a potential role for this inhibitor in fat mass modulation under research conditions
AOD-9604 Research Exclusions and Evidence Gaps AOD-9604 is a research compound with no FDA-approved indication for any patient population
Step-by-Step Guide: Considering AOD-9604 Seek Professional Advice: Because AOD-9604 is not FDA-approved for weight loss, begin by consulting a qualified healthcare professional
Targeted Fat Reduction : AOD 9604 specifically addresses resistant fat areas that often don't respond to conventional weight loss methods
This method allows for the rapid absorption of vitamins into the bloodstream
Administration Instructions Intramuscular Injection Instructions Reconstitution Instructions Subcutaneous Injection Instructions 503A vs 503B 503A pharmacies compound products for specific patients whose prescriptions are sent by their healthcare provider
